Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

FDA provides guidance to help increase supply of influenza vaccines

The U.S. Food and Drug Administration (FDA) has issued final recommendations to increase the supply of safe and effective influenza vaccines for both seasonal and pandemic use.

3 Jun 2007

Ranbaxy successfully challenges Atorvastatin patents in Norway

Ranbaxy Laboratories Limited (RLL) announced that the Norwegian Appeals Court today handed down a favorable decision for Ranbaxy in its case against Pfizer, involving key Norwegian patents on Atorvastatin in Norway.

1 Jun 2007

New TB vaccines could protect all strains

New tuberculosis (TB) vaccines in development have the potential to provide protection against all strains of TB, including multidrug-resistant (MDR) and extensively drug- resistant (XDR) TB, Dr. Jerald C.

1 Jun 2007

FDA completes review of FluMist

MedImmune, Inc. has announced that the U.S. Food and Drug Administration (FDA) has stated the agency has completed its review of all submissions made related to the supplemental biologics license application (sBLA) to extend the age indication of FluMist (Influenza Virus Vaccine Live, Intranasal).

28 May 2007

FDA takes action against unapproved prescription versions of Mucinex

Adams Respiratory Therapeutics, Inc. reports that the Food and Drug Administration (FDA) has announced that companies must stop manufacturing and distributing unapproved timed-release dosage forms containing guaifenesin.

28 May 2007

FDA committee votes in favor of Acambis' smallpox vaccine

Acambis plc announced that the Vaccines and Related Biological Products Advisory Committee of the US Food and Drug Administration (FDA) voted unanimously that Acambis' smallpox vaccine, ACAM2000, is both safe and efficacious.

18 May 2007

Chromium 6 in drinking water may cause cancer

Researchers announced today that there is strong evidence a chemical referred to as hexavalent chromium, or chromium 6, causes cancer in laboratory animals when it is consumed in drinking water.

17 May 2007

Surgeons rebuild war veteran's nose using his own body parts

It took only seconds for the Humvee to flip over and crash on a highway near Camp Bucca in southern Iraq in August 2005.

17 May 2007

Innovative drug-delivery system for rotavirus vaccine

A thin strip that dissolves in the mouth like a popular breath-freshener could someday provide life-saving rotavirus vaccine to infants in impoverished areas.

17 May 2007

Medical marijuana advocate back in court

Ed Rosenthal the so-called 'Ganja Guru' is back in court in the United States for his second trial over the illegal sale of marijuana plants.

16 May 2007

FDA approves Evicel Fibrin surgical sealant

The U.S. Food and Drug Administration (FDA) has approved Evicel Fibrin Sealant, a liquid product that when applied topically helps control oozing from small blood vessels during surgical procedures.

16 May 2007

Being overweight or obese increases risk of traumatic workplace injury

Having a body mass index (BMI) in the overweight or obese range increases the risk of traumatic workplace injury, according to researchers at the Johns Hopkins Bloomberg School of Public Health’s Center for Injury Research and Policy. Employer-sponsored weight loss and maintenance programs should be considered as part of a well-rounded workplace safety plan.

15 May 2007

Synthetic hard and soft tissue for humans

Missing bones after an accident? Arteries destroyed by disease? An international team of DCU researchers have begun work on ways of producing synthetic hard and soft tissue for humans that could revolutionise treatment for people affected by disease and trauma.

15 May 2007

Sigma-Aldrich acquires Molecular Medicine BioServices

Sigma-Aldrich Corporation has announced that it has acquired Molecular Medicine BioServices Inc. (MMB), a biopharmaceutical contract manufacturing organization (CMO) located in Carlsbad, California, to further enhance the biologics capabilities within its SAFC Pharma business segment.

9 May 2007

Abbott seeks U.S. and E.U. approvals for Humira as a treatment for juvenile rheumatoid arthritis

Abbott has announced it has simultaneously submitted a supplemental Biologics License Application (sBLA) with the U.S. Food and Drug Administration (FDA) and a Type II Variation to the European Medicines Agency (EMEA) seeking approval to market HUMIRA (adalimumab) as a treatment for juvenile rheumatoid arthritis (JRA) in the U.S. and juvenile idiopathic arthritis (JIA) in the European Union (EU).

9 May 2007

Researchers produce tiny implants from titanium to mimick small bone in the human ear

The stirrup, a small bone in the human ear, can be accurately replicated using established production processes.

8 May 2007

FDA says beware of glycerin imported from China

The Food and Drug Administration (FDA) in the United States has issued a warning to drug manufacturers, suppliers and health professionals that counterfeit drug additives have been using diethyline glycol, or DEG as a substitute for glycerin in cough medicine, fever medication and injectable drugs.

7 May 2007

Victory Pharma acquires marketing rights for Naprelan

Victory Pharma, Inc. has announced that it has acquired the exclusive US marketing rights to its leading marketed pain product, Naprelan.

4 May 2007

Study shows effectiveness of Peramivir in mouse model of H5N1 virus infection

BioCryst Pharmaceuticals has announced that investigators at St. Jude Children's Research Hospital, Memphis, TN, reported favorable results evaluating peramivir treatment in an animal model of influenza using a highly virulent strain of H5N1 virus (an avian influenza strain that had caused fatal human infection in Viet Nam).

4 May 2007

LigoCyte Pharmaceuticals presents data showing that immunization with their influenza H1N1-VLP formulation resulted in 100% protection from H1N1 and H3N2

LigoCyte Pharmaceuticals has presented preclinical data showing that immunization with their influenza virus-like particles (VLPs) induced heterosubtypic protection in a virus challenge study.

4 May 2007